A trial comparing 2 different types of surgery to remove part of the liver (ORANGE II PLUS)
Cancer type:
Status:
Phase:
This trial compared traditional open surgery with
This trial was supported by Cancer Research UK.
Summary of results
This trial showed that the recovery time after surgery to remove cancer in the liver was improved for patients that had keyhole surgery rather than open surgery.
Results
This was a
- 166 people had open surgery
- 166 people had keyhole surgery
The team looked at how many days it took people to return to their usual activities. They found that it was:
- 5 days for people who had open surgery
- 4 days for people who had keyhole surgery
28 people in the keyhole surgery group, had to have open surgery. The reasons included bleeding and the surgeon not being able to take out a sufficient amount of normal tissue around the cancer.
For these people their recovery from surgery was 5 days. The same as the open surgery group.
Side effects
The number of people who had major complications after surgery was similar in both groups. It was:
- 28 people in the open surgery group
- 24 people in the keyhole surgery group
The main complications were:
- fluid around the abdomen (ascites)
- fluid around the lungs (pleural effusion)
Quality of life
The team found that the
They also found that people in the keyhole surgery group were more satisfied with their body image after surgery.
Treatment after surgery
After surgery some people in each group had further treatment planned. The team looked at how long after surgery they were able to start this. They found that it was:
- 62 days for people in the open surgery group
- 46 days for people in the keyhole surgery group
Conclusion
The team concluded that people who had keyhole surgery:
- were able to return to their normal activities quicker than those who had open surgery
- had a better quality of life and body image after surgery
- could have their planned treatment after surgery in a shorter time
They say that these results show there may be a bigger role for liver surgery in cancer care. And that if an experienced surgeon is available, keyhole surgery can be considered for all people having liver surgery.
More detailed information
There is more information about this research in the reference below.
Please note, the information we link to here is not in plain English. It has been written for healthcare professionals and researchers.
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial
R S Fichtinger and others
ASCO Journal of Clinical Oncology, 2024. Volume 24, issue 15, pages 1799 to 1809.
Where this information comes from
We have based this summary on the information in the article above. This has been reviewed by independent specialists (
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor John Primrose
Supported by
Cancer Research UK
NIHR Clinical Research Network: Cancer
University of Southampton Clinical Trials Unit
University Hospital Maastricht
University Hospital Southampton NHS Foundation Trust
Other information
This is Cancer Research UK number CRUK/12/048.
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040